GLP-1 weight-loss and diabetes drugs may have a future role in cancer prevention and treatment, according to new research highlighted by Citi ahead of the 2026 American Society of Clinical Oncology ...

California’s decision to remove coverage for GLP-1 medications through Medi-Cal sends a troubling message to underserved ...

Diabetes and Parkinson’s patients are facing drug shortages because of the Iran war, pharmacists have warned. Shortages of several critical medicines have become “considerably worse” over the past two ...

Cutting Medicaid coverage for obesity drugs could increase long-term costs and hurt health equity in Rhode Island, the author says.

A former USPS mail carrier was sentenced in Boston after prosecutors said he stole prescription medications from customers on his route.

Chickasaw citizen Mike Carrillo is a walking commercial for his latest passion in life — persuading others who suffer with diabetes that they too can beat the debilitating disease by switching to a ...

A Reidsville woman says defective Mounjaro injection pens left her fearing she would have to pay thousands of dollars out of ...

Enables dosing at the start of a meal, offering flexibility for children and adolescents as they manage school, sports, meals, and snacks ...

Blood pressure medications work in different ways to bring blood pressure to within an optimal range. Read on for more.

A study of nearly 8,000 patients found that many people who stop Ozempic or similar drugs do not regain significant weight.

Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with type 2 diabetes.

A major new study suggests that weight-loss injections such as Ozempic and Wegovy are rapidly changing how obesity is treated ...